GammaTile

Look for the Centers of EXCELLENCE icon. This designation recognizes an institution’s exceptional expertise in the GammaTile procedure.

find a GammaTile

treatment center

near you

If you or a loved one has been diagnosed with a brain tumor – or is facing a brain tumor recurrence – knowing your treatment options is the first step toward taking back control. GammaTile®* is a radiation treatment designed to treat brain tumors immediately at the site of removal.

Use the tool below to find physicians and medical centers near you that offer GammaTile, so you can explore whether it’s the right option for your care.

Don’t see a center near you?
Contact us – there may be options available.

Treatment centers designated as a GammaTile Center of Excellence (COE) have demonstrated an exceptional level of clinical expertise and experience in the GammaTile procedure. To achieve this COE designation, doctors and their institutions must meet annual criteria that establishes their contributions to advancements in therapy, commitment to improving patient outcomes, and dedication to supporting patient education.

GT Medical™ Technologies provides this GammaTile Center Locator to support patients who want to learn more about the GammaTile procedure by helping to connect them with providers who have demonstrated and maintain GammaTile procedure clinical proficiency. Names and details are provided for your information only. GT Medical Technologies does not regulate or control these providers, does not provide assurance with respect to their services or their general availability, and does not provide indication that these providers are more skilled or qualified than others who are providing GammaTile for brain tumors. To ensure your specific needs are properly addressed, contact the facility and/or doctor directly.

This locator should not be used as a substitute for talking with your doctor. Always consult your doctor to determine the right therapy for you.
* GammaTile is indicated as a treatment for patients with newly diagnosed malignant (cancerous) brain tumors and patients with recurrent brain tumors.
MKT-439-01